QuarkMedBench: A Real-World Scenario Driven Benchmark for Evaluating Large Language Models
Organizations: Quark Medical Team, Alibaba Group
Abstract
While Large Language Models (LLMs) excel on standardized medical exams, high scores often fail to translate to high-quality responses for real-world medical queries. Current evaluations rely heavily on multiple-choice questions, failing to capture the unstructured, ambiguous, and long-tail complexities inherent in genuine user inquiries. To bridge this gap, we introduce QuarkMedBench, an ecologically valid benchmark tailored for real-world medical LLM assessment. We compiled a massive dataset spanning Clinical Care, Wellness Health, and Professional Inquiry, comprising 20,821 single-turn queries and 3,853 multi-turn sessions. To objectively evaluate open-ended answers, we propose an automated scoring framework that integrates multi-model consensus with evidence-based retrieval to dynamically generate 220,617 fine-grained scoring rubrics (~9.8 per query). During evaluation, hierarchical weighting and safety constraints structurally quantify medical accuracy, key-point coverage, and risk interception, effectively mitigating the high costs and subjectivity of human grading. Experimental results demonstrate that the generated rubrics achieve a 91.8% concordance rate with clinical expert blind audits, establishing highly dependable medical reliability. Crucially, baseline evaluations on this benchmark reveal significant performance disparities among state-of-the-art models when navigating real-world clinical nuances, highlighting the limitations of conventional exam-based metrics. Ultimately, QuarkMedBench establishes a rigorous, reproducible yardstick for measuring LLM performance on complex health issues, while its framework inherently supports dynamic knowledge updates to prevent benchmark obsolescence.
Figures & tables
| Tier | Rubric Description | Difficulty Interpretation |
|---|---|---|
| Basic | States that the diagnostic criterion for hypertension is a systolic blood pressure 130 mmHg. | Verifies the factual accuracy of the core criterion based on recent standards. |
| Pro | Explicitly indicates that the 2023 Chinese Guidelines for the Management of Hypertension adjusted the diagnostic criteria. | Assesses the model’s adherence to clinical authority and information recency by referencing the latest guideline updates. |
| Expert | Elucidates that the threshold adjustment aims for earlier intervention, which mitigates hypertension-related risks, extends life expectancy, and reduces healthcare expenditures. | Demands an explanation of the underlying rationale for the criteria revision, accompanied by relevant clinical evidence, transcending mere factual recall. |
| Perspective | Rubric Description | Cognitive Perspective Explanation |
|---|---|---|
| Direct | States the diagnostic threshold for hypertension is 130 mmHg. | Provides information directly addressing the explicit question. |
| Depth | Elucidates that the threshold was adjusted for early control, mitigating risks, extending life expectancy, and reducing healthcare costs. | Probes the essential reasoning to understand why the standard was established at 130 mmHg. |
| Breadth | Provides common symptoms of hypertension and daily precautions. | Extends laterally to address typical symptoms and lifestyle interventions the user might implicitly care about. |
| Experimental Configuration | Weight Distribution | Concordance Ratio |
|---|---|---|
| (Essential : Important : Highlight : Pitfall) | (Correct : Reversed) | |
| Baseline (Equal Weights) | 1 : 1 : 1 : 1 | 2:1 |
| V1 (Enhanced Essential & Penalty) | 2 : 1 : 1 : 2 | 3:1 |
| V2 (Over-enhanced Core) | 3 : 1 : 1 : 3 | Slightly 3:1 |
| V3 (Differentiated Important & Highlight) | 3 : 2 : 1 : 3 | Slightly 3:1 |
| Main Category | Subcategory | Percentage (%) | Overall (%) |
|---|---|---|---|
| Clinical Care | Digestive System | 12.87 | 66.22 |
| Reproductive System | 10.88 | ||
| Integumentary System | 7.88 | ||
| Respiratory System | 6.92 | ||
| Nervous System | 6.67 | ||
| Circulatory System | 5.59 |
| Model | Essential ( ) | Important ( ) | Highlight ( ) | Pitfall ( ) | ||||
|---|---|---|---|---|---|---|---|---|
| Mean ( ) | Mean ( ) | Mean ( ) | Mean ( ) | |||||
| Qwen3-235B | 8.57 | 0.696*** | 5.39 | 0.610*** | 3.21 | 0.585** | -0.28 | 0.375* |
| DeepSeekR1-0528 | 6.64 | 0.437* | 4.07 | 0.566** | 2.39 | 0.348 | -0.35 | 0.105 |
| DeepSeekR1-671B | 8.50 | 0.751*** | 5.03 | 0.675*** | 3.07 | 0.576** | -0.64 | 0.395* |
| Doubao-Seed-1.6 | 8.28 | 0.652*** | 5.42 | 0.570** | 2.96 | 0.425* | -0.35 | 0.559** |
| GPT-5 | 5.78 | 0.130 | 3.50 | 0.154 | 2.46 | 0.211 | -0.57 | -0.181 |
| Model | Exact Match | Acceptable Deviation | Severe Deviation | MAE | Pearson |
|---|---|---|---|---|---|
| (%) | (%) | (%) | ( ) | ||
| Total Score | |||||
| Gemini 2.5 Pro | 78.6 | 14.3 | 7.1 | 3.57 | 0.56 |
| Qwen3-235B | 78.6 | 14.3 | 7.1 | 3.68 | 0.58 |
| DeepSeekR1-0528 | 75.0 | 14.3 | 10.7 | 4.25 | 0.34 |
| Doubao-Seed-1.6 | 71.4 | 21.4 | 7.1 | 3.82 | 0.45 |
| Evaluation Dimension | Rubric Level | Total | Preliminary | Confirmed | Confirmed | Severity | |
|---|---|---|---|---|---|---|---|
| Rubrics (A) | Issues (B) | Issues (C) | Error Rate (C/A) | Minor | Major | ||
| Correctness | Essential | 719 | 87 | 59 | 8.21% | 44 | 15 |
| Important | 698 | 64 | 49 | 7.02% | 41 | 8 | |
| Highlight | 735 | 59 | 42 | 5.71% | 36 | 6 | |
| Pitfalls | 428 | 15 | 10 | 2.34% | 8 | 2 | |
| Subtotal | 2580 | 225 | 160 | 6.20% | 129 | 31 | |
| Rubric Level | Total | Preliminary | Confirmed | Confirmed | Discrepancy Type | ||
| Rubrics (A) | Discrepancies (B) | Discrepancies (C) | Rate (C/A) | Overestimated | Underestimated | Redundant | |
| Essential | 719 | 58 | 13 | 1.81% | 13 | 0 | 0 |
| Important | 699 | 47 | 16 | 2.29% | 12 | 3 | 1 |
| Highlight | 734 | 32 | 11 | 1.50% | 0 | 3 | 8 |
| Pitfalls | 428 | 8 | 2 | 0.47% | 0 | 0 | 2 |
| Total | 2580 | 145 | 42 | 1.63% | 25 | 6 | 11 |
| Rank | Model | Avg. | Base | Ablation Study (Score %) | ||
|---|---|---|---|---|---|---|
| Length | Score (%) | w/ Saturation | w/ Truncation* | w/ Both* | ||
| 1 | GPT-5 | 1,007 | 79.84 | 68.88 | 78.30 | 67.63 |
| 2 | Gemini 2.5 Pro | 1,935 | 74.57 | 66.87 | 72.42 | 65.10 |
| 3 | Qwen3-30B-A3B-Thinking-2507 | 2,044 | 74.54 | 66.15 | 71.64 | 63.72 |
| 4 | DeepSeek-V3.2 | 1,629 | 71.43 | 64.51 | 68.37 | 61.93 |
| 5 | GPT-5.1 | 1,473 | 70.90 | 63.99 | 68.07 | 61.62 |
| Rank | Model | Avg. | Base | Ablation Study (Score %) | ||
|---|---|---|---|---|---|---|
| Length | Score (%) | w/ Saturation | w/ Truncation* | w/ Both* | ||
| 1 | GPT-5 | 1,029 | 82.17 | 70.38 | 80.71 | 69.26 |
| 2 | GPT-5.2 | 944 | 72.52 | 65.59 | 67.42 | 61.77 |
| 3 | GPT-5.1 | 1,063 | 69.02 | 63.42 | 65.91 | 60.58 |
| 4 | Qwen3-235B-A22B | 980 | 67.71 | 60.94 | 63.28 | 57.26 |
| 5 | Qwen3-30B-A3B-Thinking-2507 | 977 | 66.23 | 60.10 | 61.59 | 56.14 |
| Rank | Model | Avg. | Overall | Dimensional Score Rate (%) | |||
|---|---|---|---|---|---|---|---|
| Length | Score (%) | Essential | Important | Highlight | Pitfall | ||
| 1 | GPT-5 | 1,007 | 79.84 | 92.23 | 81.54 | 56.04 | -4.30 |
| 2 | Gemini 2.5 Pro | 1,935 | 74.57 | 91.58 | 74.64 | 45.01 | -6.39 |
| 3 | Qwen3-30B-A3B-Thinking-2507 | 2,044 | 74.54 | 89.69 | 74.37 | 49.11 | -6.23 |
| 4 | DeepSeek-V3.2 | 1,629 | 71.43 | 89.48 | 72.29 | 41.86 | -8.66 |
| 5 | GPT-5.1 | 1,473 | 70.90 | 88.40 | 72.32 | 40.37 | -7.78 |
| Rank | Model | Avg. | Overall | Dimensional Score Rate (%) | |||
|---|---|---|---|---|---|---|---|
| Length | Score (%) | Essential | Important | Highlight | Pitfall | ||
| 1 | GPT-5 | 1,029 | 82.17 | 93.90 | 85.09 | 58.36 | -4.21 |
| 2 | GPT-5.2 | 944 | 72.52 | 89.35 | 73.33 | 41.22 | -5.15 |
| 3 | GPT-5.1 | 1,063 | 69.02 | 87.92 | 69.21 | 36.63 | -7.38 |
| 4 | Qwen3-235B-A22B | 980 | 67.71 | 84.74 | 69.62 | 45.11 | -13.53 |
| 5 | Qwen3-30B-A3B-Thinking-2507 | 977 | 66.23 | 83.49 | 66.57 | 42.93 | -11.81 |
| Model | HealthBench (HB) | QuarkMedBench (QB) | Rank | ||||
|---|---|---|---|---|---|---|---|
| Score (%) | Avg. Length | Rank | Score (%) | Avg. Length | Rank | ||
| GPT-5 | 65.56 | 1,364 | 1 | 79.84 | 1,007 | 1 | – |
| GPT-5.2 | 62.72 | 1,267 | 2 | 66.19 | 788 | 7 | 5 |
| GPT-5.1 | 62.20 | 1,802 | 3 | 70.90 | 1,473 | 4 | 1 |
| Gemini 2.5 Pro | 55.90 | 1,959 | 4 | 74.57 | 1,935 | 2 | 2 |
| Doubao Seed 1.6 | 54.78 | 1,425 | 5 | 61.91 | 1,052 | 9 | 4 |
Appendix figures & tables2 assets
Supplementary material from the paper’s appendix.
Appendix
| Main Category | Subcategory | Percentage (%) | Overall (%) |
|---|---|---|---|
| Clinical Care | Nervous System | 11.79 | 55.84 |
| Respiratory System | 7.69 | ||
| Circulatory System | 6.14 | ||
| Integumentary System | 6.03 | ||
| Digestive System | 5.87 | ||
| Musculoskeletal System | 5.27 |
LLM Evaluation
Large language model evaluation measures what models can do, how reliably they do it, and whether benchmark scores predict real-world performance.
See all 2,408 papers